Skip to main content

NCI Bottom Line: A Blog about Grants and More

This grantee-focused blog covers the latest on NCI’s fiscal landscape, funding decisions, grants policy news, processes, and more.

    • Accelerating Progress: NCI Annual Plan and Budget Proposal for FY 2022
      , by L. Michelle Bennett, Ph.D.

      In this blog, Dr. Michelle Bennett, director of NCI’s Center for Research Strategy, provides an overview of the FY 2022 Annual Plan and Budget Proposal. This blog post highlights NCI’s proposal to increase paylines and showcases patient stories that inform our scientific strategy and planning.

      Continue Reading >

    • Global Leaders in Cancer Research Partner on Cancer Grand Challenges
      , by Dr. Dinah S. Singer

      For this edition of the NCI Bottom Line, Dr. Singer highlights what NCI and CRUK’s new partnership, Cancer Grand Challenges, means for cancer research. Cancer Grand Challenges will fund novel ideas by multidisciplinary research teams from around the world that offer the potential to advance bold cancer research and improve outcomes for people affected by cancer.

      Continue Reading >

    • NCI Initiatives on the Human Immune Response to SARS-CoV-2
      , by Dr. Douglas R. Lowy and Dr. Dinah S. Singer

      Following up to her most recent NCI Bottom Line post, Dr. Dinah Singer, along with Dr. Doug Lowy, provides readers an update on SeroNet, and expands on three additional components of the network. In addition to the Centers of Excellence and serological sciences projects, Drs. Lowy and Singer provide in-depth details about the SeroNet Serology Lab, Serological Sciences Capacity Building Centers, and a SeroNet Coordinating Center.

      Continue Reading >

    • NCI Seeks Applications for SeroNet COVID-19 Research
      , by Dr. Dinah S. Singer

      In light of the COVID-19 pandemic, this edition of the NCI Bottom Line by Dr. Dinah Singer highlights and expands upon NCI’s recently launched Serological Sciences Network (SeroNet). Specifically, Dr. Singer describes the five components included in this initiative, as well as elaborates on the subsequent funding opportunities.

      Continue Reading >

    • NCI Presents 13 Research Concepts to Board of Scientific Advisors
      , by Paulette Gray, Ph.D.

      In this edition of the NCI Bottom Line, the Director of the Division of Extramural Activities, Dr. Paulette Gray, discusses the concepts presented at the recent virtual Board of Scientific Advisors meeting. While this blog links to and recaps all 13 concepts presented, Dr. Gray highlights the Glioblastoma Therapeutics Network, CISNET Incubator Program for New Cancer Sites, and the Pediatric Preclinical Testing Public Private Partnership (PPTP3).

      Continue Reading >

    • Cancer Research in the Era of COVID-19
      , by Dr. Dinah S. Singer

      In response to Dr. Singer’s presentation at the virtual 2020 annual meeting of the American Association for Cancer Research (AACR), this edition of the NCI Bottom Line highlights examples of how NCI continues to make progress in cancer research during the era of COVID-19. Dr. Singer also provides details on how NCI, working with NIH, has implemented new flexibilities for the cancer research community during this crisis.

      Continue Reading >

    • Cancer Research Training in the Era of COVID-19
      , by Dr. Oliver Bogler

      Following Dr. Sharpless’s most recent NCI Bottom Line post about NCI’s grant operations during the COVID-19 pandemic, the Center for Cancer Training’s (CCT) director, Dr. Oliver Bogler, addresses grantees about cancer research training during this unprecedented time. He also advises the cancer research community to continue to follow NIH/NCI grants guidance and suggests some ideas for how grantees and trainees can use their time.

      Continue Reading >

    • NCI Funding during the COVID-19 Public Health Emergency
      , by NCI Director, Dr. Norman E. Sharpless

      In this edition of the NCI Bottom Line, NCI Director Dr. Norman E. Sharpless addresses the grantee community about NCI funding and operations during the COVID-19 public health emergency. Dr. Sharpless highlights NCI’s peer review schedule, our program staff, as well as general NCI grants administration processes during this time.

      Continue Reading >

    • NCI Plans Policy Changes on Percent of Effort Required on Grants
      , by NCI Deputy Director, Dinah S. Singer, Ph.D.

      For this edition of the NCI Bottom Line, NCI Deputy Director, Dr. Dinah Singer elaborates on her February 11th presentation to the National Cancer Advisory Board. In this blog, Dr. Singer highlights a potential new policy from the NCI regarding a plan to implement minimum level of effort requirements for the following type of grants: U01, R01, R21, and P01.

      Continue Reading >

    • FY 2020 Budget Boost for NCI Increases Research Awards, Improves Paylines
      , by NCI Director, Dr. Norman E. Sharpless

      For this edition of the NCI Bottom Line, NCI Director, Dr. Norman E. Sharpless provides an update to the fiscal year (FY) 2020 budget and what exactly that means for NCI, research awards and paylines. Dr. Sharpless further discusses the grant policies that surround both competing and noncompeting grants from NCI.

      Continue Reading >

    • Living in Budget Limbo Under a Continuing Resolution
      , by Patrick McGarey

      For this edition of the NCI Bottom Line, Patrick McGarey, NCI’s Associate Director of Finance and Legislation provides an overview of NCI’s interim funding policy for Fiscal Year 2020. Furthermore, this blog post highlights the historical nature of functioning under a continuing resolution, and what a continuing resolution means for the NCI, as well as NCI’s grantee community.

      Continue Reading >

    • Envisioning NCI’s Future: Annual Plan and Budget Proposal for FY 2021
      , by L. Michelle Bennett, Ph.D.

      For this edition of the NCI Bottom Line, Dr. Michelle Bennett, director of NCI’s Center for Research Strategy, provides an overview of NCI’s FY2021 Annual Plan and Budget Proposal. In the blog, Dr. Bennett highlights priorities from the Plan that are especially relevant to current and future NCI-funded researchers, including supporting more investigator-initiated research and maximizing opportunities in emerging areas of science.

      Continue Reading >

    • Welcome to NCI Bottom Line: A Blog about Grants and More!
      , by NCI Staff

      For this inaugural blog post, NCI Bottom Line editors spoke with NCI Acting Director, Dr. Douglas R. Lowy, about why NCI is launching a new blog on everything you ever wanted to know about grants and how NCI funds its grants portfolio. In this Q&A, Dr. Lowy shares his vision for keeping the extramural community informed and engaged on NCI grants and funding policies.

      Continue Reading >